Global22 May 2026 at 11:24 am
Global Development Accelerates Further: Henlius' PD-L1 ADC HLX43 Completes First Patient Dosing in EU for Phase 2 MRCT

More Stories

More Stories
By pressing the subscribe button, you confirm that you have read our privacy policy.